KS

Kosha Sanjay Jha

Active Director Director DIN 07808757
DIN 07808757 First appointment Jun 2017 Primary industry General Business
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Jun 2017
Shareholding value •••• Premium profile

About Kosha Sanjay Jha

Data last updated:

Kosha Sanjay Jha has 9 years in corporate governance. Holds Director and Additional Director roles. Currently with 4 companies, including Santis Hospital And Research Institute Private Limited and Miral Pharmaceuticals Private Limited. Formerly with 3 companies, such as Advanov Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹14.18 Cr; the largest is Santis Pharmaceuticals Private Limited at ₹13.90 Cr (FY 2021).

DIN 07808757
Primary Designation Director
First Appointment 12 Jun 2017
Oldest Company Age 19 yrs
Largest company Santis Pharmaceuticals Private Limited · ₹13.90 Cr (FY 2021)
Combined revenue ₹14.18 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director09 Apr 20222010₹13.90 Cr (FY 2021)Active
Emzor Exports Private Limited U51909GJ2007PTC050786
Additional Director09 Apr 20222007₹0.24 Cr (FY 2017)Active
Director28 Jan 20212021₹0.05 Cr (FY 2025)Active
Director12 May 20212021–Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Advanov Pharma Private Limited U74999GJ2017PTC097840
Director12 Jun 20172017₹22.68 Cr (FY 2024)Active
Director05 Apr 20192012–Strike Off
Nosak Healthcare Private Limited U24230GJ2009PTC058623
Director05 Apr 20192009–Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Santis Hospital And Research Institute Private Limited
Miral Pharmaceuticals Private Limited
Santis Pharmaceuticals Private Limited
Nosak Healthcare Private Limited
Premium access

Shareholding and investment profile for Kosha Sanjay Jha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kosha Sanjay Jha

Kosha Sanjay Jha has 9 years in corporate governance. Holds Director and Additional Director roles. Currently with 4 companies, including Santis Hospital And Research Institute Private Limited and Miral Pharmaceuticals Private Limited. Formerly with 3 companies, such as Advanov Pharma Private Limited. Engaged in General Business, Healthcare. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹14.18 Cr; the largest is Santis Pharmaceuticals Private Limited at ₹13.90 Cr (FY 2021).

Kosha Sanjay Jha is associated with 4 companies as Director and Additional Director, including Santis Pharmaceuticals Private Limited (₹13.90 Cr), Emzor Exports Private Limited (₹0.24 Cr), Elanz Pharmaceuticals Private Limited (₹0.05 Cr).

Kosha Sanjay Jha has expertise in General Business, Healthcare.

Kosha Sanjay Jha has 9 years in corporate governance.

By reported revenue, the largest current company of Kosha Sanjay Jha is Santis Pharmaceuticals Private Limited, with revenue of ₹13.90 Cr (FY 2021).

The 3 current companies of Kosha Sanjay Jha that report revenue have a combined latest revenue of ₹14.18 Cr.

Kosha Sanjay Jha currently holds positions at 4 companies: Santis Pharmaceuticals Private Limited (₹13.90 Cr), Emzor Exports Private Limited (₹0.24 Cr), Elanz Pharmaceuticals Private Limited (₹0.05 Cr), Santis Hospital And Research Institute Private Limited.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available